Department of Medical Ethics, University Medical Center Utrecht, Division Julius Center, Utrecht, The Netherlands.
Hum Mutat. 2011 Aug;32(8):861-7. doi: 10.1002/humu.21518. Epub 2011 Jun 30.
This article discusses whether and when researchers have a moral obligation to feedback individual genetic research results. This unsettled debate has rapidly gained in urgency in view of the emergence of biobanks and the advances in next-generation sequencing technology, which has the potential to generate unequalled amounts of genetic data. This implies that the generation of many known and unknown genetic variants in individual participants of genetics/genomics research as intentionally or collaterally obtained byproducts is unavoidable. As we conclude that valid reasons exist to adopt a duty to return genetic research results, a qualified disclosure policy is proposed. This policy contains a standard default package, possibly supplemented with (one or more of) three additional packages. Whereas the default package, containing life-saving information of immediate clinical utility, should be offered routinely and mandatory to all research participants, offering (one of) the three additional packages is context-specific. Such a qualified disclosure policy in our opinion best balances the potential benefits of disclosure with the potential risks for research participants and the harms of unduly hindering biomedical research. We appeal to the genetics community to make a joint effort to further refine the packages and set thresholds for result selection.
本文讨论了研究人员是否有道德义务反馈个体遗传研究结果,以及在何种情况下有此义务。鉴于生物库的出现和下一代测序技术的进步,这一尚未解决的争议迅速变得紧迫起来,后者有可能产生前所未有的大量遗传数据。这意味着在遗传学/基因组学研究中,个体参与者的许多已知和未知遗传变异不可避免地会被有意或附带作为副产品获得。由于我们得出了有充分理由采取返还遗传研究结果的义务的结论,因此提出了一项有条件的披露政策。该政策包含一个标准的默认方案,可能会补充(一个或多个)三个附加方案。默认方案包含具有直接临床应用价值的救生信息,应常规且强制提供给所有研究参与者,而提供(其中之一)三个附加方案则取决于具体情况。我们认为,这种有条件的披露政策在平衡披露的潜在好处与研究参与者的潜在风险以及过度阻碍生物医学研究的危害方面做得最好。我们呼吁遗传学界共同努力,进一步完善方案并为结果选择设定阈值。